Best regulatory information management software

Overview

Regulatory information management (RIM) software is a compact market. Once you filter out clinical trial systems, generic document management, and GRC tools that share the keyword, a handful of purpose-built platforms remain, and each one covers a different slice of the job: eCTD publishing and validation, registration and post-approval lifecycle tracking, health authority correspondence and commitment logging, and regulatory document control under 21 CFR Part 11. This guide covers seven options we could evaluate with public evidence, plus one featured platform, and it does not pad the list to hit an arbitrary count.

The buyer this guide is written for is a mid-size pharma, biotech, or medical device company (roughly 200 to 1,000 employees) with a 25-person regulatory affairs and operations team managing filings across the US, EU, and a handful of international markets. Your goal is to consolidate submission planning, eCTD validation, registration tracking, and health authority correspondence into one auditable system, replacing spreadsheets and shared drives.

The options split into three groups. Full RIM suites (Veeva RIM, Ennov RIM) unify registrations, publishing, and archiving on one data model, at enterprise cost and enterprise implementation effort. Specialist platforms (Rimsys for MedTech, MasterControl for teams already on its eQMS, RegDesk) cover part of the job well and leave gaps elsewhere. Services-led providers (Artixio, MMS Holdings) sell people and consulting engagements rather than a system your team administers.

For the mid-market team whose core job is preparing, validating, and coordinating submissions without a six-figure suite commitment, Assyro is the strongest fit on this list. It is a regulatory submission workspace with validation and readiness checks built into the submission workflow, version synchronization across the storage systems you already use, and an eCTD validator, which maps directly to the highest-weighted job in this comparison.

Featured Option

Assyro is AI regulatory submission software for pharma, biotech, and medical device teams. Rather than replacing your document infrastructure with a monolithic suite, Assyro provides a shared regulatory submission workspace that layers drafting, validation, routing, readiness checks, and document and version coordination on top of the systems your team already works in, with connections to tools such as SharePoint, Box, and Google Drive described on its document management page.

Where it fits. Assyro targets the exact workflow that consumes most of a 25-person RA team's time: getting submission content drafted, reviewed, validated, and filing-ready without version drift. The platform covers three connected areas, documented on its product pages:

• Submission management (source): a shared workspace for drafting and review, with validation and readiness checks embedded in the submission workflow so defects surface before filing rather than at the gateway.
• Document management (source): version history and document synchronization across systems, with shared comments, named owners, and traceability so review accountability is visible.
• Lifecycle management (source): deadline-driven workflow automation for milestone-based submission tasks and reminders.

Assyro also publishes free FDA-focused reference tools, including an eCTD validator for detecting technical defects before filing and FDA Orange Book lookup pages for drug reference data. For a team filing NDAs, ANDAs, or 510(k)s, the ability to run readiness checks inside the same workspace where content is drafted is the practical differentiator: rework is caught in cycle, not after publishing.

Pricing. Custom quote, contact Assyro for pricing scoped to your team size and submission volume. For the 25-seat, ~40-submission scenario used throughout this guide, a scoped conversation is the fastest path to a real number.

Tradeoff to weigh. Assyro is a submission workspace first. If your primary requirement is a structured global registration registry with XEVMPD/IDMP data submission to EMA, evaluate it alongside Veeva RIM or Ennov RIM, which are built around that data model. For teams whose bottleneck is submission preparation, validation, and document coordination, that focus is the point.

Next step: Book a regulatory submission workflow demo.

Shortlist of the Best regulatory information management software

1. Assyro (Featured) — best for pharma, biotech, and device teams that need a submission workspace with built-in validation, readiness checks, and version coordination across existing storage systems.

2. Veeva RIM — best for enterprise-scale unified RIM: registrations, submissions, continuous eCTD publishing, and archive on one Vault data model.

3. Ennov RIM — best for EU-heavy portfolios needing XEVMPD submission automation, IDMP readiness, and a structured registration system of record.

4. RegDesk — a dedicated RIM system, though limited public documentation makes independent evaluation difficult before a sales conversation.

5. Rimsys — best for MedTech manufacturers managing UDI, device registrations, and multi-market lifecycle tracking across 100+ markets.

6. MasterControl — best for teams already on MasterControl's eQMS that want connected registration tracking and AI-assisted regulatory research.

7. Artixio — best for teams that want outsourced regulatory operations (eCTD publishing, registrations) plus AI regulatory intelligence, delivered as services.

8. MMS Holdings — best for sponsors that want submission preparation (IND, NDA, BLA) outsourced to a CRO with AI-assisted regulatory writing.

How We Chose

This shortlist reflects the purpose-built options in this market that we could evaluate with public evidence, not a curated top-N cut from a longer list. Two entries that appeared during research were excluded as data artifacts: a search-engine redirect page with no product behind it, and a review-directory listing page that carried no evaluable product documentation. Neither is a purchasable RIM product, so neither appears in the reviews below.

We evaluated each option qualitatively against the criteria that matter most for the 25-seat, ~40-submission buyer scenario:

• eCTD publishing and validation depth: can the platform compile, validate, and publish eCTD submissions, or detect technical defects before filing?
• Registration and post-approval lifecycle tracking: does it track registrations, variations, and renewals across markets in one system of record?
• 21 CFR Part 11 / Annex 11 compliance and audit trails: are e-signatures, audit trails, and role-based access documented?
• Regulatory document management and version control: controlled review workflows, version history, and traceability.
• Health authority correspondence and commitment tracking: can HA questions and commitments be logged and linked to products and submissions?
• Implementation and data migration effort: what does it take to get from spreadsheets to a working system?

We prioritized official product and pricing pages, then public review signals from G2, Capterra, and Gartner Peer Insights where they exist, over directory popularity. One scope note: this market includes other established vendors (LORENZ, EXTEDO, ArisGlobal, Calyx, and IQVIA among them) that we did not independently evaluate with comparable evidence, so this guide does not claim to cover every vendor in the category. It covers the options where public evidence supports a real comparison.

Comparison Table

Detailed Reviews

1. Veeva RIM

Fit. Veeva RIM (the Vault RIM Suite) is the category-leading unified option, used by 200+ life sciences companies including four of the top 10 global pharmas, per Veeva's product page. It suits organizations that want registrations, submission authoring, publishing, and archive on one platform and can absorb enterprise licensing and implementation costs.

Standout capabilities.

• Vault Registrations: plan, track, and report global product registrations including packaging, indications, and manufacturing details, with impact assessment for label and manufacturing changes and support for XEVMPD and IDMP data requirements.
• Vault Submissions: authoring, review, approval, and assembly with eCTD binder templates and submission content plans auto-generated from templates (eCTD and DIA EDM Reference Model taxonomy), with document reuse across plans and markets.
• Vault Submissions Publishing: continuous publishing and validation of eCTD dossiers as documents are authored and approved, with transmission to health authority gateways. Customer Melinta reported cutting submission development time in half and publishing 100 submissions in its first two months.
• Vault Submissions Archive: storage and search of submitted applications and HA correspondence, with commitment tracking via dedicated Commitment and Regulatory Objective data objects.
• Integrations include Microsoft Office co-authoring inside Vault, Veeva Connections to Vault Quality, Clinical, and Safety, and direct health authority gateway dispatch.

Pricing. Quote-based; Veeva publishes no list prices. Third-party benchmarks (IntuitionLabs, 2026) put small biotech RIM (1–3 users) at ~$15K–$45K/year, growing teams (3–8 users) at ~$45K–$120K/year, and general Vault fees around $50–$200/user/month. Extrapolated to the 25-seat scenario, expect roughly $150K–$250K/year across the suite, plus a further $50K–$180K one-time for implementation and validation. Implementation services are benchmarked at 30–92% of first-year license fees, with one mid-size biotech example at ~$300K implementation on ~$325K annual licensing. Note that named-user licensing stacks per application: a user needing both Submissions and Registrations consumes two licenses.

Review signals. Veeva Vault RIM has a small public review base: 10 reviews on G2, with RIM-relevant reviews among 28 verified Veeva Vault reviews on Capterra. G2 reviewers score Dossier Management at 9.9 and Audit Trails at 10.0, and score the product 9.4 on meeting requirements. Reviewers praise native connections across Veeva modules for staying audit-ready and report Vault does not freeze or crash on large documents, unlike systems they used previously. Criticisms: a regulatory consultant on Capterra finds the data model cumbersome (the interplay between an event, a submission, a regulatory objective, and an application is complicated), reviewers describe workflows as click-heavy and rigid with PDF rendering problems, the main search bar only searches documents by default, and license and training costs are called very high compared to similar tools.

Bottom line. The most complete RIM suite available, priced and scoped for organizations that can commit six figures annually plus a substantial implementation project.

2. Ennov RIM

Fit. Ennov RIM centralizes product, registration, submission, health authority correspondence, and commitment data in a single structured system of record, per its RIM product page. It is built for RA and regulatory operations teams, with particular strength for EU-heavy portfolios, and offers cloud or on-premises deployment.

Standout capabilities.

• Registration and lifecycle tracking across the full lifecycle: regulatory activity planning where information is entered once and replicated across products, countries, and applications.
• XEVMPD automation: messages are compiled, validated, and submitted to EMA through Ennov RIM, with IDMP readiness via the Ennov IDMP module.
• Impact analysis: see which registrations are affected by a change such as a manufacturer update or formulation change.
• Native module linkage: connections to Ennov Doc (EDMS) and Ennov Dossier (eCTD publishing) give automatic linkage between substances, products, registrations, activities, dossiers, submissions, and documents.
• Out-of-the-box dashboards for submissions, correspondence, commitments, and PSUR tracking; Microsoft Power BI integration via Ennov InSight RIM; configurable data models for pharmaceuticals, biologics, devices, veterinary products, and cosmetics.

Pricing. Quote-based. Software Advice lists Ennov Regulatory Suite pricing as available on request, and Capterra confirms no free version and no free trial. No per-seat or per-module dollar figures are published anywhere, so a 25-seat buyer cannot budget without a sales cycle.

Review signals. Ennov holds a 4.5-star rating from 3 verified reviews on G2, with additional product-level reviews on Capterra (6 for Ennov Doc) and Gartner Peer Insights. Reviewers report that entity administrators do not need IT knowledge (RA, QA, or supply staff can manage the solution themselves), that all Ennov modules are linked, and one Ennov Doc customer scaled from 3,500 documents at go-live to nearly 19,700 over about 5 years. Criticisms: a Gartner Peer Insights reviewer notes product improvements can take a very long time and the administration interface is hard to navigate, a Software Advice reviewer flags the lack of generalized batch actions in RIM settings, and Capterra reviewers of the clinical products report a dated interface and performance limits at large data volumes.

Bottom line. A credible unified alternative to Veeva with strong EU data-submission automation, but the full value depends on adopting multiple Ennov modules (RIM + Doc + Dossier + IDMP), and pricing requires a sales cycle.

3. RegDesk

Fit. RegDesk positions its product as a regulatory information management system for tracking regulatory information. Beyond that positioning, limited public product documentation is available for independent evaluation, so this entry is necessarily thinner than the others.

What we can verify. RegDesk markets a dedicated RIM system. Specific feature depth (eCTD publishing, correspondence tracking, Part 11 controls), named integrations, and public review signals were not retained in our research, so we cannot compare RegDesk on those dimensions as if they were known.

Pricing. Pricing is unverified. There is no public pricing page, and cost details require a sales conversation.

Review signals. No usable public review signal was retained for this vendor.

Tradeoffs. The practical impact of thin public documentation is that your evaluation timeline extends: every capability question (validation depth, audit trails, data model, migration approach) has to be answered in vendor demos rather than desk research, and you cannot pressure-test claims against published documentation before committing meeting time.

Bottom line. Potentially relevant for teams specifically seeking a dedicated RIM registry, but scope it through direct vendor demos with a written requirements checklist, since independent pre-evaluation is not currently possible.

4. Rimsys

Fit. Rimsys is a cloud RIM platform purpose-built for MedTech, connecting regulatory intelligence, product data, registrations, submissions, UDI, and change management on a shared structured product-data foundation. Per rimsys.io, six of the world's top 12 medical device manufacturers use it, with lifecycle tracking spanning 100+ markets.

Standout capabilities.

• Native UDI module (add-on): automated UDI updates as product registrations change, EUDAMED/GUDID/ROW compliance, and electronic GUDID and EUDAMED submissions listed as coming soon. Rimsys states it uniquely bundles this into RIM.
• Submissions tooling: real-time co-authoring with embedded Word-compatible editing, auto-generated submission table of contents and appendices, reusable snippets, cover letters, and letterheads, PDF publishing of submission packages, and government-specific templates (STED, CSTD, 510(k), EU MDR/IVDR, Australia, Brazil, China, and more).
• Registration tracking: certificate management with automated renewal reminders, correspondence tracking with health agencies, and country market entrance requirements.
• Compliance posture stated on its pricing page: 21 CFR Part 11 compliant (electronic storage, e-signatures, audit logs), validated to ISO 13485:2016, GxP compliant infrastructure, ISO 27001 certified ISMS, and SOC2 Type 2.
• Integrations: ERP, PLM, QMS/eQMS, CRM, and labeling systems via API (several as add-ons), BI sync to Snowflake and Google Analytics via Rimsys Connect, and OAuth 2.0 SSO included for all customers at no extra cost.

Pricing. Quote-based. The pricing page describes flexible pricing but publishes no dollar figures, tier names, minimums, or trial. Key UDI capabilities and PLM/ERP/labeling integrations are explicitly priced as add-ons, which raises total cost for device teams that need them.

Review signals. No usable public review signal was retained for this vendor.

Tradeoffs. Purpose-built for MedTech means the platform does not describe eCTD publishing/validation or NDA/ANDA pharma submission workflows. A mixed pharma/device buyer needing eCTD compilation for FDA drug filings would need a separate tool alongside Rimsys.

Bottom line. The strongest device-specific option on this list. If your portfolio is devices and UDI/EUDAMED obligations are real, shortlist it; if you file drug dossiers, it covers only half your problem.

5. MasterControl

Fit. MasterControl Regulatory Excellence is the RIM arm of MasterControl's GxP platform, automating registration and submissions processes with content collection, dossier management, change control, and document lifecycle tools, per its regulatory page. Its distinct angle is connecting regulatory and quality management as a shared system of record, so teams already on MasterControl's eQMS can extend into RIM without a second vendor.

Standout capabilities.

• Registrations 510(k) module: for each device, visibility into every geography where it is registered plus corresponding requirements, and inversely all products up for approval or re-registration in each location, which maps directly to multi-market renewal tracking.
• Regulatory Chat: a natural-language AI over FDA and EU MDR corpuses (including the eCFR) with in-line citations, developed in compliance with ISO 42001, with groundwork for analyzing SOPs against regulations for gap analysis.
• Included validation tooling: the patented Validation Excellence Tool (VxT) and Validation on Demand come with the subscription rather than as paid add-ons. One TrustRadius reviewer noted "The VxT validation tool has saved us months in validation."
• Change workflows: one change form spanning multiple products, low/medium/high impact classification, and routine/temporary/emergency categorization with training, validation, and regulatory impact prompts.
• Integrations: MuleSoft iPaaS with prebuilt connectors, the MasterControl API Toolkit, ERP/CRM/MES/PDM connectivity via Integration Services, LIMS data synchronization, and Microsoft Word, Excel, and PowerPoint forms conversion.

Pricing. Quote-based with no published figures on mastercontrol.com/pricing. Third-party signals: Capterra lists MasterControl Quality Excellence starting at $25,000/year for the Basic plan; OpenRegulatory's research puts pricing at ~$25K/year scaling toward $100K/year; a TrustRadius reviewer cited ~$1,700/user licensing. For the 25-seat scenario, that implies roughly $58,750/year (25 × $1,700 = $42,500 plus a multi-module uplift), a low-confidence estimate since the actual price is quote-only and implementation is extra.

Review signals. Beyond the specific third-party comments cited above, reviewers report the named-user license model can be cost-prohibitive for smaller businesses and becomes very expensive as it scales, since reviewers, approvers, and read-only stakeholders each consume licenses.

Tradeoffs. No native eCTD publishing/validation engine is described on its RIM pages. A team filing NDAs and ANDAs at volume would likely still need a dedicated eCTD publishing tool (such as LORENZ or EXTEDO) alongside it, which changes the total cost and integration picture.

Bottom line. The natural choice if MasterControl is already your QMS and registration visibility is the gap; a partial answer if eCTD publishing depth is your first requirement.

6. Artixio

Fit. Artixio is an integrated global regulatory and commercial consulting firm supporting pharmaceuticals, medical devices, biologics, cosmetics, and dietary supplements, with a network of experts across 120+ countries, per artixio.com. It combines consulting with proprietary AI platforms such as QuriousRI. It is a services-led provider, not a standalone eCTD/RIM publishing platform.

Standout capabilities.

• Global expert coverage: over 250 regulatory experts across 120+ countries specializing in new product registration, post-approval maintenance, dossier preparation, submission, and health authority liaison, which is direct in-country coverage most pure-software RIM vendors do not offer.
• Regulatory operations as a service: eCTD publishing, artwork, and labeling delivered via project-based and FTE-based models, so a 25-seat RA team can offload publishing volume instead of buying publishing seats.
• QuriousRI: AI-powered regulatory intelligence covering health authority guidelines with real-time update tracking, integrated with QuriousRI-GP for strategy, planning, and gap analysis simulation. AI teams track updates automatically while regulatory experts review them to prepare summaries and risk analysis, human-in-the-loop rather than raw feeds.
• Qurious-Compass for food, health supplements, and cosmetics navigation, plus a cosmetic ingredients compliance check drawing on databases including Cosing, PubChem, IFRA, REACH, and 21 CFR.
• Deployment flexibility: web-based applications or solutions deployed onsite within a client's IT environment per their security policies. ISO 9001:2015 certified at the company level.

Pricing. Quote-based. No dollar figures, tiers, or plan names appear on artixio.com; QuriousRI access is arranged by writing to info@artixio.com, and consulting work is sold via project-based and FTE-based models. No per-seat estimate can be calculated for the 25-seat scenario.

Review signals. No usable public review signal was retained for this vendor.

Tradeoffs. Artixio's cited RIM software page is a researched list of RIM software available in the market (covering Veeva, IQVIA, EXTEDO, Ennov, and others), not an Artixio product page. Buyers wanting a self-administered eCTD publishing/validation and registration-tracking system will need one of the platforms Artixio itself lists. And the services model means submission throughput depends on Artixio staff availability, not in-house tooling your team controls, a real tradeoff for teams wanting an auditable in-house system of record with Part 11 e-signatures. No published role-based permission, e-signature, or Part 11 configuration documentation exists for the Qurious platforms.

Bottom line. A strong option for offloading multi-country registration work and regulatory intelligence to experts; not a substitute for RIM software your team operates.

7. MMS Holdings

Fit. MMS Holdings is a data-focused contract research organization, not a productized RIM software vendor. Its regulatory information management page is an educational article defining RIMS capabilities, while its technology centers on the Datacise clinical data platform and KerusCloud trial simulation. For regulatory buyers, MMS delivers services: strategy consulting, submission support, and AI-assisted regulatory writing.

Standout capabilities.

• Submission services coverage: IND, NDA, BLA, OTC switches, 505(b)(2)/ANDA (FDA) and Hybrid/Variation/Extension (EMA) pathways, plus expedited pathway support for Fast Track, Breakthrough Therapy, Accelerated Approval, and PRIME.
• AI-assisted writing: an AI cloud application for regulatory documents, clinical study reports, and plain language summaries, with a vendor-stated reduction of average Draft 1 authoring time by up to 50%.
• CMC and pediatric specialization: Module 2.3 Quality Overall Summary and Module 3 authoring, pediatric investigational plans (PIPs), pediatric study plans (PSPs), pediatric written requests, and health authority meeting preparation and follow-up.
• Datacise platform on Microsoft Azure: Curate (ETL and aggregation of structured and unstructured clinical data), Analyze (ML, NLP, and network graphs built on Python and R with R Shiny visualizations), and Explore (API-based data extraction, dashboards, automated SAS dataset transfers). KerusCloud provides statistical modeling and trial simulation on AWS.

Pricing. Quote-based. No pricing, tiers, or dollar figures appear on the extracted pages; engagements are scoped as service projects or FSP (functional service provider) arrangements, and Datacise access is bundled into sponsor engagements. No per-seat or per-submission figure can be normalized for the 25-seat scenario.

Review signals. No usable public review signal was retained for this vendor.

Tradeoffs. There is no productized RIM system here. The named technology (Datacise, KerusCloud) targets clinical data visualization, RWD analytics, and trial simulation, not eCTD publishing depth, registration and variation lifecycle tracking, or HA correspondence logging in a system of record. A team that needs an in-house RIM platform will not find one at MMS.

Bottom line. The right call when you want submission preparation done for you by a CRO; the wrong category if you need software your RA team runs.

How to Choose the Right regulatory information management software

Work through these filters in order.

Filter 1: Do you need software your team operates, or services? If submission throughput should be outsourced, Artixio (multi-country registration operations, eCTD publishing as a service) and MMS Holdings (IND/NDA/BLA preparation from a CRO) are the legitimate paths. Everyone else should keep reading.

Filter 2: Is submission preparation and validation your core bottleneck? For the mid-market team described in this guide, whose daily pain is drafting, review coordination, version drift, and pre-filing defect detection across ~40 submissions a year, Assyro is the recommended default. Its validation and readiness checks live inside the submission workflow, its eCTD validator catches technical defects before filing, and it synchronizes documents with SharePoint, Box, and Google Drive rather than forcing a document migration. That combination addresses the highest-weighted criterion in this comparison (eCTD validation depth) with the lowest structural disruption.

Filter 3: Is a global registration data model your first requirement? If you need XEVMPD messages submitted to EMA and IDMP-structured product data as the system's center of gravity, Veeva RIM and Ennov RIM are the purpose-built answers. Veeva is the deeper, more expensive suite (est. $150K–$250K/year at 25 seats before implementation); Ennov is the EU-automation specialist with quote-based pricing and a multi-module dependency.

Filter 4: Is your portfolio devices only? Rimsys is the narrow-fit winner: native UDI, EUDAMED/GUDID compliance (add-on), 510(k)/STED/EU MDR templates, and registration tracking across 100+ markets. If you already run MasterControl's eQMS, MasterControl's Registrations 510(k) module extends what you have.

Filter 5: Can you evaluate before a sales call? Assyro, Veeva, Ennov, Rimsys, and MasterControl publish enough product documentation for desk research. RegDesk currently does not, so budget demo time accordingly.

Key Features to Look For in regulatory information management software

• Pre-filing validation and readiness checks. Defects caught during authoring cost minutes; defects caught at the gateway cost a filing cycle. Assyro builds validation and readiness checks into the submission workflow and offers a standalone eCTD validator; Veeva's continuous publishing validates dossiers as documents are approved.
• Version control and document synchronization. Version drift between the EDMS and the submission is the classic RIM failure mode. Assyro maintains version history and synchronizes documents across systems including SharePoint, Box, and Google Drive; Ennov links documents to dossiers natively when you adopt Ennov Doc.
• Ownership and traceability. Look for named owners, shared comments, and audit trails on every document and task. Assyro documents shared comments, owners, and traceability on its document management page; Rimsys and MasterControl document Part 11-aligned e-signatures and audit logs.
• Registration and renewal lifecycle tracking. For ~300 tracked registrations, you need renewal reminders and change impact analysis. Veeva, Ennov, Rimsys, and MasterControl all document this; verify data model fit for your product hierarchy in demos.
• HA correspondence and commitment tracking. Veeva uses dedicated Commitment and Regulatory Objective objects; Ennov ships correspondence and commitment dashboards; Rimsys tracks health agency correspondence.
• Deadline-driven workflow automation. Milestone-based tasks and reminders keep 40 concurrent submissions from slipping. Assyro documents this on its lifecycle management page.
• Implementation and migration effort. Suite implementations are projects: Veeva implementation services benchmark at 30–92% of first-year license fees. A workspace that layers on existing storage, as Assyro does, shortens the path from spreadsheets to a working system.

Pricing and Cost Considerations

No vendor on this list publishes a full public rate card, so treat every figure below as a scoped-conversation starting point. Normalized to the 25 RA seats / ~40 active submissions per year scenario:

Hidden cost drivers to press on in every sales conversation:

• Per-module license stacking. Veeva users need a license per application they touch, so a person working in both Submissions and Registrations consumes two. MasterControl's named-user tiers mean reviewers and read-only approvers add cost; reviewers report the model becomes very expensive as it scales.
• Implementation and validation services. Veeva's are benchmarked at 30–92% of first-year license fees. MasterControl includes its VxT validation tooling in the subscription, which reviewers credit with saving months of validation work.
• Add-ons. Rimsys prices UDI automation, EUDAMED/GUDID compliance, and PLM/ERP/labeling integrations as add-ons on top of the base platform.
• Companion tooling. MasterControl's RIM pages describe no native eCTD publishing engine, so budget for a separate publishing tool if you file NDAs and ANDAs.

On pricing posture, Assyro is quote-based like every option here. The practical difference is scope: because it layers on your existing storage rather than replacing your EDMS, the quote conversation is about seats and submission workflow, not a suite-and-migration program. Book a regulatory submission workflow demo to get a scoped number.

Adjacent Options in the regulatory information management software Landscape

These options came up during research but solve a different workflow than the RIM platforms above; they are listed neutrally, without scoring.

• Freyr Solutions — a regulatory services and consulting provider whose RIM-related pages are educational resources; relevant if you are exploring outsourced regulatory support rather than licensing RIM software.
• Gartner Digital Markets — a vendor listing and discovery directory, useful for expanding a shortlist but not itself a RIM product.
• G2 research (life sciences categories) — G2's editorial and category research on life sciences software, a discovery resource rather than a purchasable tool.

Assyro vs Other Options

Assyro vs Veeva RIM. Veeva RIM is the full unified suite (Registrations, Submissions, Publishing, Archive on one data model), with third-party benchmarks putting a 25-user deployment around $150K–$250K/year plus $50K–$180K implementation. Assyro is a lighter AI submission workspace with an eCTD validator and connections to SharePoint, Box, and Google Drive. Choose Veeva for enterprise-scale global registration tracking, continuous eCTD publishing, and IDMP/XEVMPD compliance; choose Assyro for collaborative drafting, readiness checks, and document coordination without a six-figure suite commitment.

Assyro vs Ennov RIM. Ennov centralizes registrations, correspondence, and commitments as a structured system of record with automated XEVMPD submissions to EMA and IDMP readiness, but its full value depends on adopting multiple Ennov modules (RIM + Doc + Dossier + IDMP), and pricing is quote-only with no free trial. Assyro layers a submission workspace over the storage tools you already use, with built-in validation and version synchronization. Choose Ennov for EU-heavy portfolios needing XEVMPD/IDMP data management; choose Assyro if you are keeping your current EDMS and want drafting and readiness checks on top of it.

Assyro vs RegDesk. RegDesk is positioned as a RIM system, but public documentation is limited and pricing requires a sales conversation, so independent evaluation is difficult. Assyro documents concrete capabilities: validation and readiness checks, version history, an eCTD validator, and connections to SharePoint, Box, and Google Drive. Teams that need to evaluate features before a sales call are better served starting with Assyro; teams specifically seeking a dedicated RIM registry should scope RegDesk through direct demos.

Assyro vs Rimsys. Rimsys is purpose-built for MedTech, with a native UDI module (EUDAMED/GUDID as an add-on), STED/CSTD/510(k) templates, and registration tracking across 100+ markets, but it does not describe eCTD publishing or NDA/ANDA pharma workflows. Assyro spans pharma, biotech, and devices and includes an eCTD validator plus FDA Orange Book reference tools. Choose Rimsys for device manufacturers managing UDI and multi-market registrations; choose Assyro for mixed pharma/biotech teams needing eCTD validation and shared drafting.

Assyro vs MasterControl. MasterControl's differentiator is unifying RIM with its eQMS (Registrations 510(k) tracking, Regulatory Chat AI over FDA/EU MDR corpuses, included VxT validation tooling), with third-party estimates around $25K–$100K/year and ~$1,700/user licensing, though its pages describe no native eCTD publishing engine. Assyro focuses on the submission workflow itself, with an eCTD validator, readiness checks, and document sync. Choose MasterControl if you already run its QMS and need connected registration tracking; choose Assyro when submission drafting and eCTD validation are the primary job.

Assyro vs Artixio. Artixio sells regulatory operations as a service: 250+ experts across 120+ countries, eCTD publishing on project or FTE models, and the QuriousRI intelligence platform, but no self-administered RIM system your team controls. Assyro gives your RA team an in-house workspace with validation, readiness checks, and traceable ownership. Choose Artixio to offload multi-country registration work to in-country experts; choose Assyro to keep submission preparation, and its audit trail, inside your own team.

Assyro vs MMS Holdings. MMS is a CRO offering IND/NDA/BLA submission services and AI-assisted regulatory writing (vendor-stated up to 50% reduction in Draft 1 authoring time), with technology aimed at clinical data analytics rather than RIM. Assyro is software your team operates daily for drafting, validation, and version coordination. Choose MMS to outsource submission authoring for a specific program; choose Assyro to build lasting in-house submission capacity across ~40 filings a year.

FAQ

Do any of these vendors publish pricing?

No vendor on this list publishes a complete public rate card. The most useful third-party benchmarks are for Veeva (roughly $45K–$120K/year for 3–8 RIM users, per IntuitionLabs) and MasterControl (Capterra lists a $25,000/year starting point for Quality Excellence; one TrustRadius reviewer cited ~$1,700/user). Everything else, including Assyro, requires a scoped quote, so build a vendor conversation into your budgeting timeline.

Do I need a full RIM suite, or is a submission workspace enough?

It depends on where your risk concentrates. If regulatory inspections keep finding inconsistent registration data or missed commitments, you need a registration system of record (Veeva, Ennov, Rimsys for devices). If your rework comes from version drift, late validation failures, and uncoordinated review cycles, a submission workspace with built-in validation, which is Assyro's design, addresses the problem directly without a suite migration.

How should I handle eCTD validation if my RIM platform does not publish?

MasterControl and Rimsys, for example, do not describe pharma eCTD publishing engines. You can pair them with a dedicated publishing tool, or run pre-filing checks through a validator such as Assyro's eCTD validator so technical defects surface before the dossier reaches a gateway.

What should I verify in demos that this guide cannot?

Three things the public evidence cannot settle: how each data model handles your specific product hierarchy (Veeva reviewers on Capterra call its event/submission/regulatory-objective interplay complicated), real migration effort from your spreadsheets and shared drives, and admin workflows for your reviewer and approver roles. Bring a real product family and a recent submission as test cases.

How much should I budget for implementation on top of licenses?

For suites, a lot: Veeva implementation services benchmark at 30–92% of first-year license fees, with one mid-size biotech example at ~$300K one-time on ~$325K annual licensing. MasterControl includes its VxT validation tooling in the subscription, which reduces that burden. Workspace-style tools that connect to existing storage, like Assyro, avoid the document-migration component entirely; confirm rollout scope in your demo.

Conclusion

This is a compact market, and the right choice tracks your primary constraint more than any overall ranking. For the mid-market regulatory team, 25 RA seats, roughly 40 active submissions a year, filings across the US, EU, and a handful of international markets, Assyro is the default starting point: validation and readiness checks inside the submission workflow, version synchronization with SharePoint, Box, and Google Drive, an eCTD validator for pre-filing defect detection, and traceable ownership across review cycles, without a suite migration.

The narrow cases route elsewhere. Choose Veeva RIM if you need the full unified suite and can fund six-figure annual licensing plus a substantial implementation. Choose Ennov RIM for EU-centric portfolios where XEVMPD automation and IDMP readiness lead the requirements. Choose Rimsys if you are a device manufacturer with UDI and multi-market registration obligations. Choose MasterControl if its eQMS is already your quality backbone. Choose Artixio or MMS Holdings if the honest answer is that you want the work done for you rather than software to do it in. Scope RegDesk through demos if a dedicated RIM registry is your specific requirement.

Start where your submissions actually live: book a regulatory submission workflow demo with Assyro and bring a current dossier to test the readiness checks against.